Selecting effective antisense reagents on combinatorial oligonucleotide arrays View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1997-06

AUTHORS

Natalie Milner, Kalim U. Mir, Edwin M. Southern

ABSTRACT

An array of 1,938 oligodeoxynucleotides (ONs) ranging in length from monomers to 17-mers was fabricated on the surface of a glass plate and used to measure the potential of oligonucleotide for heteroduplex formation with rabbit β-globin mRNA. The oligonucleotides were complementary to the first 122 bases of mRNA comprising the 5′ UTR and bases 1 to 69 of the first exon. Surprisingly few oligonucleotides gave significant heteroduplex yield. Antisense activity, measured in a RNase H assay and by in vitro translation, correlated well with yield of heteroduplex on the array. These results help to explain the variable success that is commonly experienced in the choice of antisense oligonucleotides. For the optimal ON, the concentration required to inhibit translation by 50% was found to be five times less than for any other ON. We find no obvious features in the mRNA sequence or the predicted secondary structure that can explain the variation in heteroduplex yield. However, the arrays provide a simple empirical method of selecting effective antisense oligonucleotides for any RNA target of known sequence. More... »

PAGES

537-541

Journal

TITLE

Nature Biotechnology

ISSUE

6

VOLUME

15

Related Patents

  • Antisense Modulation Of Protein Phosphatase 2 Catalytic Subunit Beta Expression
  • Antisense Inhibition Of Ptp1b Expression
  • Clusterin Antisense Therapy For Treatment Of Cancer
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Ligase Detection And Polymerase Chain Reactions
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Ligase Detection With Padlock Probes And Polymerase Chain Reactions
  • Permits Multiplex Detection Of Nucleic Acid Sequence Differences; Ldr Coupled To Pcr; Primary Pcr Coupled To Secondary Pcr Coupled To Ldr; And Primary Pcr Coupled To Secondary Pcr; Each Have Particular Applicability In Detecting Certain Characteristics
  • A 21-Base Antisense Oligonucleotide Which Inhibits Gene Expression Of Testosterone-Repressed Prostate Message-2 By Tumor Cells; Prostate And Renal Cell Cancer; Enhanced Chemosensitivity, Hormone And Radiation Sensitivities
  • Hybrid Nucleic Acids; Prevent, Controlling Gene Expression; Antiinflammatory Agents
  • Detecting Preferential Exons Within Genomes; Obtain Sample, Incubate With Probes, Detect Hybridization In Genome, Map Binding Profile
  • Antisense Modulation Of Src-1 Expression
  • Determination Of Structure Formation In Nucleic Acid Targets; Obtain Folded Target Nucleotide Sequences, Incubate With Oligonucleotide Probes, Monitor Conformation Of Hybridized Structures
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Compositions And Methods Of Targeting Apolipoprotein B For The Reduction Of Apolipoprotein C-Iii
  • Rna Interference Mediated Inhibition Of Gene Expression Using Short Interfering Nucleic Acids (Sina)
  • Antisense Modulation Of Syntaxin 4 Interacting Protein Expression
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Ligase Detection And Polymerase Chain Reactions
  • Very Short Bcl-2 Antisense Oligonucleotides Ranging From 7-9 Bases In Lipid Formulations; Induce Growth Inhibition In Human Leukemic Cells; Combined With Uncharged Lipid And A Carrier; Anticarcinogenic Agents; Tissue-Targeted Therapy; Nucleic Sequences
  • Antisense Modulation Of Pecam-1
  • Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (Ctgf)
  • Antisense Oligonucleotide Modulation Of Stat3 Expression
  • Trpm-2 Antisense Therapy Using An Oligonucleotide Having 2′-O-(2-Methoxy)Ethyl Modifications
  • Modulation Of Cd40 Expression
  • Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
  • Modulation Of Signal Transducer And Activator Of Transcription 3 (Stat3)Expression
  • Target-Dependent Reactions Using Structure-Bridging Oligonucleotides
  • Modulation Of The Expression Of The Pka Regulatory Rii Subunit Alpha May Provide A Means Of Regulating The Expression Of Pka; Modulation Of Its Activity Is A Potential Strategy With Which To Treat Metabolic Or Developmental Disorders
  • Target-Dependent Reactions Using Structure-Bridging Oligonucleotides
  • Antisense Modulation Of Dual Specific Phosphatase 5 Expression
  • Device For Identifying Sequences In Multiplex Analysis To Identify Genetic Disorders, In Forensics Or Food Safety Use; Support Functionalized With Silanes And/Or Ethenically Unsaturated Monomers For Repeatedly Hybridizing Oligonucleotides To Capture Probes
  • Antisense Modulation Of Ptp1b Expression
  • Anticarcinogenic Agent Is Conjugated With A Nucleic Acids, For Cancer Treatment; A Kit For Detection; Chemical Intermediates
  • Forming A Ligation Product On A Target Nucleotide Sequence; Amplifying The Product; Detecting The Amplified Product, And Identifying The Target Nucleotide Sequence; Multiplex Methods
  • Trpm-2 Antisense Therapy
  • Antisense Modulation Of Sr-Cyp Expression
  • Treatment Of Cancer By Inhibition Of Igfbps And Clusterin
  • Folate Derived Conjugates Of Double Stranded Nucleic Acids, Used For The Delivery Of Drugs To Specific Cell Types
  • Antisense Modulation Of Pka Regulatory Subunit Rii Alpha Expression
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Antisense Inhibition Of Cyclin D2 Expression
  • Chemo- And Radiation-Sensitization Of Cancer By Antisense Trpm-2 Oligodeoxynucleotides
  • Antisense Oligonucleotides Targeted To Superoxide Dismutase 1(Sod1) , For Use In Inhibiting The Expression Of Sod1 In The Central Nervous System Of An Individual For Slowing Amyotrophic Lateral Sclerosis; Oligonucleotide With Modified Sugar Base, Phosphorothioate Linkage, 5-Methylcytosine Nucleobase
  • Modulation Of Signal Transducer And Activator Of Transcription 3 (Stat3) Expression
  • Detection Of Preferential Nucleotide Sequences On Solid Support; Generate Solid Support, Incubate With Nucleotide Sequences, Expose To Probe, Detect Signal, Presence Of Signal Indicates Preferential Nucleotide Sequences
  • Trpm-2 Antisense Therapy
  • Antisense Modulation Of Superoxide Dismutase 1, Soluble Expression
  • P53 Antisense Agent And Method
  • Antisense Modulation Of Ptp1b Expression
  • Oligonucleotide Of Given Dna Sequence Which Specifically Hybridizes With One Of Said Regions And Inhibits The Expression Of The Enzyme; Can Use In Treating Diabetes And Cancer
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Ligase Detection And Polymerase Chain Reactions
  • Antisense Inhibition Of Map Kinase Kinase 6 Expression
  • Compositions And Methods For Treating Pancreatic Cancer
  • Methods Of Inhibiting Cancer Cells With Adnf Iii Antisense Oligonucleotides
  • Chemically Modified Multifunctional Short Interfering Nucleic Acid Molecules That Mediate Rna Interference
  • Methods For Placing, Accepting, And Filling Orders For Products And Services
  • Methods For Slowing Familial Als Disease Progression
  • Antisense Modulation Of Protein Kinase C-Theta Expression
  • Modified Protein Kinase A-Specific Oligonucleotides And Methods Of Their Use
  • Modulation Of Hematopoietic Cell; Controlling Cell Differentiation, Cell Proliferation
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Polymerase Chain Reactions
  • Estrogen Receptor Site-Specific Ribozymes And Uses Thereof For Estrogen Dependent Tumors
  • Antisense Modulation Of Sr-Cyp Expression
  • Method For Identifying Accessible Binding Sites On Rna
  • Antisense Modulation Of Ptp1b Expression
  • Estrogen Receptor Site-Specific Ribozymes And Uses Thereof For Estrogen Dependent Tumors
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Hiv Infection Inhibitors
  • Preparing Oligonucleotide Sequences; Providing An Apparatus Which Contains Stored Oligonucleotides, Heat The Apparatus, Polymerize The Nucleotide Sequences, Release And Recover The Nucleotide Sequences
  • For Therapy Of Hiv Infection
  • Antisense Oligonucleotides Against Tenascin For Treating Vitiligo
  • Antisense Inhibition Of Rad51
  • Anticarcinogenic/Antitumor/Antiproliferative Agents And Diagnostic Agents Targeted Against Gene Which Codes For A Protein Kinase Involved In Signal Transduction
  • Antisense Oligonucleotide Modulation Of Mdr P-Glycoprotein Gene Expression
  • Modulation Of Cd40 Expression
  • Antisense Modulation Of Superoxide Dismutase 1, Soluble Expression
  • A Therapy Method For Cellular Senescence Or Increased Proliferation By Administering A Therapeutic Agent To Cells That Reduces Loss Of Telomere Repeats During Proliferation
  • Chemo- And Radiation-Sensitization Of Cancer By Antisense Trpm-2 Oligodeoxynucleotides
  • Modulation Of Signal Transducer And Activator Of Transcription 3 (Stat3) Expression
  • Rna Interference Mediated Inhibition Of Gene Expression Using Short Interfering Nucleic Acids (Sina)
  • Antisense Modulation Of Connective Tissue Growth Factor Expression
  • Conjugates And Compositions For Cellular Delivery
  • Antisense Inhibition Of Ets-2 Expression
  • Methods For Analyzing Nucleic Acid
  • Rna Interference Mediated Inhibition Of Gene Expression Using Short Interfering Nucleic Acids (Sina)
  • Antisense Modulation Of Sphingosine-1-Phosphate Lyase Expression
  • Enzymatic Polypeptide For Use In The Diagnosis And Treatment Of Cancer
  • Conjugates And Compositions For Cellular Delivery
  • Compositions For Modulating Sod-1 Expression
  • Antisense Inhibition Of Nucleolin Expression
  • An Antisense Nucleotide; Therapy For Metabolic Diseases, Diabetes
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Administering Antisense Oligonucleotides Complementary To Human Apolipoprotein B
  • Inhibitors Of Tgf-R Signaling For Treatment Of Cns Disorders
  • Antisense Modulation Of Apolipoprotein B Expression
  • Antisense Modulation Of Lar Expression
  • Sap-1 (Serum-Response Factor Accessory Protein-1); Oligonucleotides Targeted To Nucleic Acids Encoding Sap-1; Use In Treatment Of Cancer; Anti-Cancer Agents
  • Treatment Of Cancer By Inhibition Of Igfbps And Clusterin
  • Antisense Modulation Of Ptp1b Expression
  • Antisense Treatments For Melanoma By Inhibition Of Clusterin, Also Known As Testosterone-Repressed Prostate Message-2, For Example By Administration Of Antisense Oligonucleotides Specific For Clusterin
  • An Oligonucleotide That Encodes A Human Protein Kinases Involved In Signal Transduction Regulating Cell Proliferation; Anticarcinogenic/Antitumor Agents, Diagnosis And Therapy Of Psoriasis, Artherosclerosis, Tissue Grafts
  • Methods For Inhibiting Expression Of Connective Tissue Growth Factor
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Ligase Detection And Polymerase Chain Reactions
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Method Of Designing Addressable Array Suitable For Detection Of Nucleic Acid Sequence Differences Using Ligase Detection Reaction
  • Antisense Modulation Of Ptp1b Expression
  • Using Primer Mismatches To Identify And Amplify Polymorphic Target Gene Sequences; Mutational Analysis; Multiplex Detection Of Nucleic Acid Sequence Differences
  • Antisense Modulation Of Ptp1b Expression
  • Antisense Modulation Of Ptp1b Expression
  • Antisense Modulation Of Chk2 Expression
  • Antisense Modulation Of Stearoyl-Coa Desaturase Expression
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Using Primer Mismatches To Identify And Amplify Polymorphic Target Gene Sequences; Mutational Analysis; Multiplex Detection Of Nucleic Acid Sequence Differences
  • Antisense Modulation Of Lar Expression
  • Detecting Nucleic Acids In Samples By Binding A Fluorescently Labeled Nucleic Acid Probe, Having A Hairpin Structure, To A Solid Phase; Solid Phase Quenches The Label If The Hairpin Structure Exists; Analyzing Nucleic Acid Sequences
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Inhibition Of Bcl-2 Protein Expression By Liposomal Antisense Oligodeoxynucleotides
  • Nucleotide Sequences; Oligonucleotides
  • Modulation Of Fetoprotein Transcription Factor Expression
  • Hybrid Nucleic Acids; Controlling Gene Expression
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Polymorphism Analysis By Nucleic Acid Structure Probing
  • Method For Reducing Scarring During Wound Healing Using Antisense Compounds Directed To Ctgf
  • Method Of Designing Addressable Array Suitable For Detection Of Nucleic Acid Sequence Differences Using Ligase Detection Reaction
  • For Environmental/Forensic/Food/Feed Monitoring; Kits, Solid Phase Synthesis
  • Method For Identifying Accessible Binding Sites On Rna
  • Antisense Modulation Of Fra-1 Expression
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Compositions For Modulating Sod-1 Expression
  • Chemically Modified Multifunctional Short Interfering Nucleic Acid Molecules That Mediate Rna Interference
  • Antisense Modulation Of Stearoyl-Coa Desaturase Expression
  • Antisense Modulation Of Integrin Beta 4 Binding Protein Expression
  • Compounds And Methods For Modulating Expression Apob
  • Antisense Modulation Of Sr-Cyp Expression
  • Method Of Designing Addressable Array Suitable For Detection Of Nucleic Acid Sequence Differences Using Ligase Detection Reaction
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Forming A Ligation Product On A Target Nucleotide Sequence; Amplifying The Product; Detecting The Amplified Product, And Identifying The Target Nucleotide Sequence; Multiplex Methods
  • Oligonucleotides Which Hybridize Nucleic Acids Which Encode Said Enzymes; Gene Therapy; Genetic Engineering; For Treatment Of Abnormal Lipid Metabolism, Athersclerosis, And Cardiovascular Disease
  • Antisense Inhibition Of Hpk/Gck-Like Kinase Expression
  • Gene Expression Inhibition; Treating Developmental Disorders Or Aberrant Apoptosis
  • Antisense Modulation Of Cd40 Expression
  • Clusterin Antisense Therapy For Treatment Of Cancer
  • Gene Expression Inhibition; Antiproliferative, Anticancer And Antiarthritic Agents; Angiogenesis Inhibitors
  • Methods And Compositions For Diagnosis And Treatment Of Pathological Conditions Related To Abnormal Dopamine Receptor Expression
  • Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
  • Treatment Of Cancer By Inhibition Of Igfbp's And Clusterin
  • Trpm-2 Antisense Therapy
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Compositions For Modulating Sod-1 Expression
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Treatment Of Cancer By Inhibition Of Igfbps And Clusterin
  • Nucleotide Sequences That Prevent The Expression Of A Human Polypeptide That Prevent Apoptosis In Tumor Cells; Anticarcinogenic Agents
  • Antisense Modulation Of Ptp1b Expression
  • Antisense Modulation Of Survivin Expression
  • Stress-Phosphorylated Endoplasmic Reticulum Protein, Nogo B, For Therapy
  • Methods For Placing, Accepting, And Filling Orders For Products And Services
  • Antisense Modulation Of Il-1 Receptor-Associated Kinase-4 Expression
  • Antisense Modulation Of Glioma-Associated Oncogene-3 Expression
  • Snps Of Apolipoprotein B And Modulation Of Their Expression
  • Administration Of A Chemotherapeutic Agent And A Formulation Containing A Cationic Liposomes Which Consists Of Cationic Lipid, Phosphatidylcholine And Cholesterol And Having Encapsulated Therein An Oligonucleotide
  • Comprises Oligonucleotide Probes For Hybridization; Medical Diagnosis
  • Nucleotide Sequences For Use As Tool In Controlling Protein Tyrosine Phosphatase-1b Gene Expression And Treatment Of Diabetes; Gene Expression Inhibition
  • Treatment Of Cancer By Inhibition Of Igfbps And Clusterin
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Antisense Modulation Of Ptp1b Expression
  • Antisense Oligonucleotide Modulation Of Stat3 Expression
  • Detection Of Nucleic Acid Sequence Differences Using Coupled Ligase Detection And Polymerase Chain Reactions
  • Oligonucleoside Compounds And Methods For Inhibiting Tumor Growth, Invasion And Metastasis
  • Detecting The Presence Of A Target Nucleic Acid Molecule By Detecting Non-Target Cleavage Products
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof
  • Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
  • Modified Protein Kinase A-Specific Oligonucleotides And Methods Of Their Use
  • Method Of Designing Addressable Array For Detection Of Nucleic Acid Sequence Differences Using Ligase Detection Reaction
  • Antisense Modulation Of Superoxide Dismutase 1, Soluble Expression
  • Analyzing Nucleotide Sequences And Detecting Sequence Adjustments; Mixing Preferential Nucleotide Sequences And Conformation Activating Sequences, Recover Cleavage Products
  • Reduces The Expression Of Testosterone-Repressed Prostate Message-2 Provides Therapeutic Benefits In The Treatment Of Cancer For Example Prostate Cancer And Renal Cell Cancer; Combined Use With Taxanes Synergistically Enhances Cytotoxic Chemosensitivity Of Androgen-Independent Prostate Cancer
  • Antisense Modulation Of Cd40 Expression
  • Method Of Designing Addressable Array Suitable For Detection Of Nucleic Acid Sequence Differences Using Ligase Detection Reaction
  • Detection Of Nucleic Acid Sequence Differences Using The Ligase Detection Reaction With Addressable Arrays
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nbt0697-537

    DOI

    http://dx.doi.org/10.1038/nbt0697-537

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1022203075

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/9181575


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Genetics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Base Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Exons", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Globins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Sequence Data", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nucleic Acid Conformation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nucleic Acid Heteroduplexes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Oligodeoxyribonucleotides", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "RNA, Messenger", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rabbits", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transcription, Genetic", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK", 
              "id": "http://www.grid.ac/institutes/grid.4991.5", 
              "name": [
                "Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Milner", 
            "givenName": "Natalie", 
            "id": "sg:person.01247714071.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247714071.41"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK", 
              "id": "http://www.grid.ac/institutes/grid.4991.5", 
              "name": [
                "Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mir", 
            "givenName": "Kalim U.", 
            "id": "sg:person.01320751674.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320751674.99"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK", 
              "id": "http://www.grid.ac/institutes/grid.4991.5", 
              "name": [
                "Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Southern", 
            "givenName": "Edwin M.", 
            "id": "sg:person.01050717725.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050717725.08"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nm0696-668", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039646445", 
              "https://doi.org/10.1038/nm0696-668"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt0796-840", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001313757", 
              "https://doi.org/10.1038/nbt0796-840"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1997-06", 
        "datePublishedReg": "1997-06-01", 
        "description": "An array of 1,938 oligodeoxynucleotides (ONs) ranging in length from monomers to 17-mers was fabricated on the surface of a glass plate and used to measure the potential of oligonucleotide for heteroduplex formation with rabbit \u03b2-globin mRNA. The oligonucleotides were complementary to the first 122 bases of mRNA comprising the 5\u2032 UTR and bases 1 to 69 of the first exon. Surprisingly few oligonucleotides gave significant heteroduplex yield. Antisense activity, measured in a RNase H assay and by in vitro translation, correlated well with yield of heteroduplex on the array. These results help to explain the variable success that is commonly experienced in the choice of antisense oligonucleotides. For the optimal ON, the concentration required to inhibit translation by 50% was found to be five times less than for any other ON. We find no obvious features in the mRNA sequence or the predicted secondary structure that can explain the variation in heteroduplex yield. However, the arrays provide a simple empirical method of selecting effective antisense oligonucleotides for any RNA target of known sequence.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nbt0697-537", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1115214", 
            "issn": [
              "1087-0156", 
              "1546-1696"
            ], 
            "name": "Nature Biotechnology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "15"
          }
        ], 
        "keywords": [
          "RNase H assays", 
          "antisense activity", 
          "effective antisense", 
          "antisense reagents", 
          "effective antisense reagents", 
          "rabbit \u03b2-globin mRNA", 
          "array", 
          "oligonucleotide", 
          "basis of mRNA", 
          "antisense", 
          "glass plate", 
          "RNA targets", 
          "h assay", 
          "heteroduplex formation", 
          "yield", 
          "oligonucleotide arrays", 
          "oligodeoxynucleotides", 
          "surface", 
          "mRNA sequences", 
          "vitro translation", 
          "heteroduplexes", 
          "assays", 
          "reagents", 
          "potential", 
          "structure", 
          "secondary structure", 
          "method", 
          "sequence", 
          "formation", 
          "concentration", 
          "monomers", 
          "translation", 
          "first exon", 
          "length", 
          "obvious features", 
          "time", 
          "activity", 
          "exons", 
          "results", 
          "simple empirical method", 
          "plate", 
          "features", 
          "\u03b2-globin mRNA", 
          "target", 
          "choice", 
          "mRNA", 
          "success", 
          "variation", 
          "basis", 
          "variable success", 
          "UTR", 
          "bases 1", 
          "empirical methods"
        ], 
        "name": "Selecting effective antisense reagents on combinatorial oligonucleotide arrays", 
        "pagination": "537-541", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1022203075"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nbt0697-537"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "9181575"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nbt0697-537", 
          "https://app.dimensions.ai/details/publication/pub.1022203075"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:47", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_289.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nbt0697-537"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nbt0697-537'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nbt0697-537'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nbt0697-537'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nbt0697-537'


     

    This table displays all metadata directly associated to this object as RDF triples.

    180 TRIPLES      21 PREDICATES      92 URIs      82 LITERALS      18 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nbt0697-537 schema:about N0de472985c4b4a82b7df612a7a5517f4
    2 N49384b7d430c44809d2ddc9e7f9727a1
    3 N58c8a138ee0b42d2b612342b673aab83
    4 N73a40beef73241f1b72951fb8fb0391b
    5 N96e0911964384698a6b2c602de90de5c
    6 N9856815e24b34d3cb75d08e213d4c80a
    7 Nb083b6f73fbf47a7967379e8a5ffad94
    8 Nc22e17d25015433fb569bf700c64b0c1
    9 Nc3f91143f43f44859c607a0399bb5079
    10 Nc92029587bef4e9c9a4b181f7d5ce78a
    11 Ncaa5175cef924fdeb7c46cffda135c0d
    12 anzsrc-for:06
    13 anzsrc-for:0604
    14 schema:author N183e3e154afc4ca2bee34ecaba4cdbc0
    15 schema:citation sg:pub.10.1038/nbt0796-840
    16 sg:pub.10.1038/nm0696-668
    17 schema:datePublished 1997-06
    18 schema:datePublishedReg 1997-06-01
    19 schema:description An array of 1,938 oligodeoxynucleotides (ONs) ranging in length from monomers to 17-mers was fabricated on the surface of a glass plate and used to measure the potential of oligonucleotide for heteroduplex formation with rabbit β-globin mRNA. The oligonucleotides were complementary to the first 122 bases of mRNA comprising the 5′ UTR and bases 1 to 69 of the first exon. Surprisingly few oligonucleotides gave significant heteroduplex yield. Antisense activity, measured in a RNase H assay and by in vitro translation, correlated well with yield of heteroduplex on the array. These results help to explain the variable success that is commonly experienced in the choice of antisense oligonucleotides. For the optimal ON, the concentration required to inhibit translation by 50% was found to be five times less than for any other ON. We find no obvious features in the mRNA sequence or the predicted secondary structure that can explain the variation in heteroduplex yield. However, the arrays provide a simple empirical method of selecting effective antisense oligonucleotides for any RNA target of known sequence.
    20 schema:genre article
    21 schema:isAccessibleForFree false
    22 schema:isPartOf N10ca54274c854f87a05b07376d27223c
    23 N2f3522bd9de34e328890d823b6e5d4d8
    24 sg:journal.1115214
    25 schema:keywords RNA targets
    26 RNase H assays
    27 UTR
    28 activity
    29 antisense
    30 antisense activity
    31 antisense reagents
    32 array
    33 assays
    34 bases 1
    35 basis
    36 basis of mRNA
    37 choice
    38 concentration
    39 effective antisense
    40 effective antisense reagents
    41 empirical methods
    42 exons
    43 features
    44 first exon
    45 formation
    46 glass plate
    47 h assay
    48 heteroduplex formation
    49 heteroduplexes
    50 length
    51 mRNA
    52 mRNA sequences
    53 method
    54 monomers
    55 obvious features
    56 oligodeoxynucleotides
    57 oligonucleotide
    58 oligonucleotide arrays
    59 plate
    60 potential
    61 rabbit β-globin mRNA
    62 reagents
    63 results
    64 secondary structure
    65 sequence
    66 simple empirical method
    67 structure
    68 success
    69 surface
    70 target
    71 time
    72 translation
    73 variable success
    74 variation
    75 vitro translation
    76 yield
    77 β-globin mRNA
    78 schema:name Selecting effective antisense reagents on combinatorial oligonucleotide arrays
    79 schema:pagination 537-541
    80 schema:productId N0fc7453ee8a346f494cf0f0b1866dac2
    81 N0fe47e5ba7ab4b5aa52a0e1c1cee17b0
    82 Ncecae4390a8b4784964fc69f56cdb882
    83 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022203075
    84 https://doi.org/10.1038/nbt0697-537
    85 schema:sdDatePublished 2022-11-24T20:47
    86 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    87 schema:sdPublisher Nb84fc8538e0e4865882e9587a06b04b5
    88 schema:url https://doi.org/10.1038/nbt0697-537
    89 sgo:license sg:explorer/license/
    90 sgo:sdDataset articles
    91 rdf:type schema:ScholarlyArticle
    92 N0de472985c4b4a82b7df612a7a5517f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    93 schema:name Exons
    94 rdf:type schema:DefinedTerm
    95 N0fc7453ee8a346f494cf0f0b1866dac2 schema:name pubmed_id
    96 schema:value 9181575
    97 rdf:type schema:PropertyValue
    98 N0fe47e5ba7ab4b5aa52a0e1c1cee17b0 schema:name dimensions_id
    99 schema:value pub.1022203075
    100 rdf:type schema:PropertyValue
    101 N10ca54274c854f87a05b07376d27223c schema:volumeNumber 15
    102 rdf:type schema:PublicationVolume
    103 N183e3e154afc4ca2bee34ecaba4cdbc0 rdf:first sg:person.01247714071.41
    104 rdf:rest N73b34fd0a53c40a6bc8337a9ecfc0695
    105 N2f3522bd9de34e328890d823b6e5d4d8 schema:issueNumber 6
    106 rdf:type schema:PublicationIssue
    107 N49384b7d430c44809d2ddc9e7f9727a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    108 schema:name Globins
    109 rdf:type schema:DefinedTerm
    110 N58c8a138ee0b42d2b612342b673aab83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    111 schema:name RNA, Messenger
    112 rdf:type schema:DefinedTerm
    113 N73a40beef73241f1b72951fb8fb0391b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    114 schema:name Nucleic Acid Conformation
    115 rdf:type schema:DefinedTerm
    116 N73b34fd0a53c40a6bc8337a9ecfc0695 rdf:first sg:person.01320751674.99
    117 rdf:rest Na4e5fef7b5e2476fa05f651841a62d9c
    118 N96e0911964384698a6b2c602de90de5c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Rabbits
    120 rdf:type schema:DefinedTerm
    121 N9856815e24b34d3cb75d08e213d4c80a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Oligodeoxyribonucleotides
    123 rdf:type schema:DefinedTerm
    124 Na4e5fef7b5e2476fa05f651841a62d9c rdf:first sg:person.01050717725.08
    125 rdf:rest rdf:nil
    126 Nb083b6f73fbf47a7967379e8a5ffad94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Base Sequence
    128 rdf:type schema:DefinedTerm
    129 Nb84fc8538e0e4865882e9587a06b04b5 schema:name Springer Nature - SN SciGraph project
    130 rdf:type schema:Organization
    131 Nc22e17d25015433fb569bf700c64b0c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Molecular Sequence Data
    133 rdf:type schema:DefinedTerm
    134 Nc3f91143f43f44859c607a0399bb5079 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Animals
    136 rdf:type schema:DefinedTerm
    137 Nc92029587bef4e9c9a4b181f7d5ce78a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Nucleic Acid Heteroduplexes
    139 rdf:type schema:DefinedTerm
    140 Ncaa5175cef924fdeb7c46cffda135c0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Transcription, Genetic
    142 rdf:type schema:DefinedTerm
    143 Ncecae4390a8b4784964fc69f56cdb882 schema:name doi
    144 schema:value 10.1038/nbt0697-537
    145 rdf:type schema:PropertyValue
    146 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    147 schema:name Biological Sciences
    148 rdf:type schema:DefinedTerm
    149 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
    150 schema:name Genetics
    151 rdf:type schema:DefinedTerm
    152 sg:journal.1115214 schema:issn 1087-0156
    153 1546-1696
    154 schema:name Nature Biotechnology
    155 schema:publisher Springer Nature
    156 rdf:type schema:Periodical
    157 sg:person.01050717725.08 schema:affiliation grid-institutes:grid.4991.5
    158 schema:familyName Southern
    159 schema:givenName Edwin M.
    160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050717725.08
    161 rdf:type schema:Person
    162 sg:person.01247714071.41 schema:affiliation grid-institutes:grid.4991.5
    163 schema:familyName Milner
    164 schema:givenName Natalie
    165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247714071.41
    166 rdf:type schema:Person
    167 sg:person.01320751674.99 schema:affiliation grid-institutes:grid.4991.5
    168 schema:familyName Mir
    169 schema:givenName Kalim U.
    170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320751674.99
    171 rdf:type schema:Person
    172 sg:pub.10.1038/nbt0796-840 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001313757
    173 https://doi.org/10.1038/nbt0796-840
    174 rdf:type schema:CreativeWork
    175 sg:pub.10.1038/nm0696-668 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039646445
    176 https://doi.org/10.1038/nm0696-668
    177 rdf:type schema:CreativeWork
    178 grid-institutes:grid.4991.5 schema:alternateName Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK
    179 schema:name Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK
    180 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...